resveratrol has been researched along with oxidopamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cojocel, C; Thomson, MS | 1 |
| Chang, RC; Chao, J; Ho, YS; Wang, M; Yu, MS | 1 |
| Gong, QH; Jin, F; Lu, YF; Shi, JS; Wu, Q | 1 |
| Chang, RC; Chao, J; Cheng, KW; Li, H; Wang, M; Yu, MS | 1 |
| Ahmad, A; Hoda, MN; Ishrat, T; Islam, F; Javed, H; Khan, A; Khan, MB; Khan, MM; Khuwaja, G; Raza, SS; Vaibhav, K | 1 |
| Chen, M; Huang, N; Jin, F; Jin, H; Luo, Y; Nie, J; Shi, J; Zhang, Y; Zhou, S | 1 |
| Fan, HX; Li, JJ; Li, XX; Sheng, S; Zhang, F; Zheng, CQ | 1 |
| Chaturvedi, S; Mishra, A; Singh, A; Singh, S; Wahajuddin, M; Yadawa, AK | 1 |
8 other study(ies) available for resveratrol and oxidopamine
| Article | Year |
|---|---|
Protective effect of resveratrol against 6-hydroxydopamine-induced impairment of renal p-aminohippurate transport.
Topics: Animals; Antioxidants; Biological Transport; Cephaloridine; Cisplatin; Culture Media; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney Cortex; Male; Oxidopamine; p-Aminohippuric Acid; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2004 |
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.
Topics: Adrenergic Agents; Antioxidants; Blotting, Western; Caspase 3; Cell Line, Tumor; Chromatography, High Pressure Liquid; Humans; L-Lactate Dehydrogenase; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Plant Extracts; Reactive Oxygen Species; Resveratrol; Stilbenes | 2008 |
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Necrosis Factor-alpha | 2008 |
Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells.
Topics: Caspase 3; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; L-Lactate Dehydrogenase; Methylation; Models, Chemical; Neurons; Neurotoxins; Oxidopamine; Phosphorylation; Resveratrol; Stilbenes | 2010 |
Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Topics: Animals; Antioxidants; Disease Models, Animal; Dopamine; Enzymes; Free Radicals; Glutathione; Lipid Peroxidation; Male; Nerve Degeneration; Neurotoxins; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Phospholipases A2; Rats; Rats, Wistar; Resveratrol; Stilbenes; Substantia Nigra; Thiobarbituric Acid Reactive Substances; Treatment Outcome | 2010 |
Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway.
Topics: Animals; Apoptosis; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Substantia Nigra | 2019 |
Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats.
Topics: Animals; Biomarkers; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Dyskinesias; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Resveratrol; Substantia Nigra | 2021 |
Mechanism for antiParkinsonian effect of resveratrol: Involvement of transporters, synaptic proteins, dendrite arborization, biochemical alterations, ER stress and apoptosis.
Topics: Animals; Antiparkinson Agents; Apoptosis; Dendrites; Disks Large Homolog 4 Protein; Dopamine Plasma Membrane Transport Proteins; Endoplasmic Reticulum Stress; Male; Neuronal Plasticity; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Rats, Sprague-Dawley; Resveratrol; Synaptophysin; Vesicular Monoamine Transport Proteins | 2021 |